\u7f8e\u56fd\u8bc1\u5238\u4ea4\u6613\u59d4\u5458\u4f1a(Securities and Exchange Commission, \u7b80\u79f0SEC)\u5468\u56db\u8868\u793a\uff0cAlexion Pharmaceuticals Inc. (ALXN)\u5c06\u652f\u4ed82150\u4e07\u7f8e\u5143<\/a><\/span>\uff0c\u4ee5\u4e86\u7ed3\u6709\u5173\u5176\u57282010\u5e74\u81f32015\u5e74\u671f\u95f4\u8d3f\u8d42\u571f\u8033\u5176\u548c\u4fc4\u7f57\u65af\u653f\u5e9c\u5b98\u5458\u4ee5\u589e\u52a0\u5176\u5904\u65b9\u836fSoliris\u5728\u5f53\u5730\u9500\u552e\u7684\u6307\u63a7\uff0c\u79f0\u8be5\u516c\u53f8\u6b64\u4e3e\u8fdd\u53cd\u4e86\u300a\u53cd\u6d77\u5916\u8150\u8d25\u6cd5\u300b(Foreign Corrupt Practices Act)\u3002Alexion\u65e2\u672a\u627f\u8ba4\u4e5f\u672a\u5426\u8ba4\u8c03\u67e5\u7ed3\u679c\uff0c\u4f46\u8be5\u6848\u4ef6\u786e\u5b9e\u8ba9Alexion\u6cbb\u7406\u72b6\u51b5\u548c\u5546\u4e1a<\/a><\/span>\u9053\u5fb7\u6210\u4e3a\u5173\u6ce8\u7126\u70b9\u3002SEC\u8fd8\u53d1\u73b0Alexion\u5728\u5df4\u897f\u548c\u54e5\u4f26\u6bd4\u4e9a\u7684\u5b50\u516c\u53f8\u4e5f\u5b58\u5728\u95ee\u9898\u3002<\/p>\n \u53bb\u5e74\uff0cAlexion\u540c\u610f\u652f\u4ed81,300\u4e07\u7f8e\u5143\uff0c\u5c312010\u5e74\u81f32016\u5e74\u671f\u95f4\u7f8e\u56fd\u8054\u90a6\u533b\u7597\u9879\u76ee\u56de\u6263\u8ba1\u5212\u76f8\u5173\u6307\u63a7\u4e0e\u53f8\u6cd5\u90e8\u8fbe\u6210\u548c\u89e3\uff0c\u8be5\u6848\u6d89\u53caSoliris\u836f\u7269\u548c\u5171\u4ed8\u5e2e\u52a9\u57fa\u91d1\u4f1a\uff0c\u5bfc\u81f4Alexion\u4efb\u547d\u4e86\u4e00\u4e2a\u65b0\u7684\u6267\u884c\u9886\u5bfc\u56e2\u961f\uff0c\u5e76\u66f4\u6362\u4e86\u4e00\u534a\u7684\u8463\u4e8b\u4f1a\u6210\u5458\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"